BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10320142)

  • 21. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cyclo-oxygenase-2 in ependymal tumors.
    Roma AA; Prayson RA
    Neuropathology; 2006 Oct; 26(5):422-8. PubMed ID: 17080719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramedullary subependymoma of the spinal cord.
    Jallo GI; Zagzag D; Epstein F
    Neurosurgery; 1996 Feb; 38(2):251-7. PubMed ID: 8869051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subependymoma with extensive microcystic transformation: a case report.
    Huang Y
    Int J Clin Exp Pathol; 2015; 8(2):2191-4. PubMed ID: 25973126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas.
    Abramovich CM; Prayson RA
    Arch Pathol Lab Med; 1999 Sep; 123(9):793-800. PubMed ID: 10458826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular and extraventricular ependymal tumors in 18 cats.
    Woolford L; de Lahunta A; Baiker K; Dobson E; Summers BA
    Vet Pathol; 2013 Mar; 50(2):243-51. PubMed ID: 22798290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic relevance of global histone 3 lysine 9 acetylation in ependymal tumors.
    Ebrahimi A; Schittenhelm J; Honegger J; Schluesener H
    J Neurosurg; 2013 Dec; 119(6):1424-31. PubMed ID: 24116725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic and proliferative markers in chordomas: a study of 26 tumors.
    Kilgore S; Prayson RA
    Ann Diagn Pathol; 2002 Aug; 6(4):222-8. PubMed ID: 12170453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical management of intracranial subependymomas.
    Kandenwein JA; Bostroem A; Feuss M; Pietsch T; Simon M
    Acta Neurochir (Wien); 2011 Jul; 153(7):1469-75. PubMed ID: 21499782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.
    Gyure KA; Prayson RA
    Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.
    Martin SA; Sears DL; Sebo TJ; Lohse CM; Cheville JC
    Am J Surg Pathol; 2002 Mar; 26(3):292-300. PubMed ID: 11859200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence-guided resection with 5-aminolevulinic Acid of subependymomas of the fourth ventricle: report of 2 cases: technical case report.
    Bernal García LM; Cabezudo Artero JM; Marcelo Zamorano MB; Gilete Tejero I
    Neurosurgery; 2015 Jun; 11 Suppl 2():E364-71; discussion E371. PubMed ID: 25950889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subependymomas: an analysis of clinical and imaging features.
    Ragel BT; Osborn AG; Whang K; Townsend JJ; Jensen RL; Couldwell WT
    Neurosurgery; 2006 May; 58(5):881-90; discussion 881-90. PubMed ID: 16639322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.
    Ho DM; Hsu CY; Wong TT; Chiang H
    J Neurooncol; 2001 Aug; 54(1):77-85. PubMed ID: 11763426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ependymomas: MIB-1 proliferation index and survival.
    Ritter AM; Hess KR; McLendon RE; Langford LA
    J Neurooncol; 1998 Oct; 40(1):51-7. PubMed ID: 9874186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical outcomes in spinal cord subependymomas: an institutional experience.
    Wu L; Yang T; Deng X; Yang C; Zhao L; Fang J; Wang G; Yang J; Xu Y
    J Neurooncol; 2014 Jan; 116(1):99-106. PubMed ID: 24062139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Findings from frozen sections of spinal subependymomas: Is it possible to differentiate this diagnosis from other common spinal tumors?
    Choi SK; Lee SH; Kim B; Minn YK; Kim KN; Kim SH
    Brain Tumor Pathol; 2016 Jan; 33(1):19-26. PubMed ID: 26515302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma.
    Bi Z; Ren X; Zhang J; Jia W
    J Neurosurg; 2015 Jan; 122(1):49-60. PubMed ID: 25361493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical aspects and pathology of intracranial subependymoma--18 personal cases and review of the literature].
    Ernestus RI; Schröder R
    Neurochirurgia (Stuttg); 1993 Nov; 36(6):194-202. PubMed ID: 8309495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.